Capstone Investment Advisors, LLC Merck & Co., Inc. Put Options Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

Put Options

26 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $6.3 Million - $7.31 Million	-56,700 Reduced 12.21%	407,500 $46.3 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $3.58 Million - $3.84 Million	28,900 Added 6.64%	464,200 $57.5 Million
Q1 2024 May 01, 2024	SELL	$113.24 - $131.95 $4.1 Million - $4.78 Million	-36,200 Reduced 7.68%	435,300 $57.4 Million
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $19.9 Million - $21.6 Million	198,400 Added 72.65%	471,500 $51.4 Million
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $14.2 Million - $15.7 Million	137,600 Added 101.55%	273,100 $28.1 Million
Q2 2023 Aug 10, 2023	BUY	$108.61 - $118.38 $2.98 Million - $3.24 Million	27,400 Added 25.35%	135,500 $15.6 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $2.74 Million - $3.06 Million	-26,600 Reduced 19.75%	108,100 $11.5 Million
Q4 2022 Feb 10, 2023	BUY	$87.44 - $112.11 $2.98 Million - $3.82 Million	34,100 Added 33.9%	134,700 $14.9 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $20.4 Million - $22.9 Million	-241,600 Reduced 70.6%	100,600 $8.66 Million
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $38.4 Million - $43.6 Million	-460,200 Reduced 57.35%	342,200 $31.2 Million
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $106 Million - $118 Million	-1,437,500 Reduced 64.18%	802,400 $65.8 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $5.79 Million - $7.25 Million	80,100 Added 3.71%	2,239,900 $172 Million
Q3 2021 Nov 15, 2021	BUY	$71.68 - $78.83 $28.8 Million - $31.7 Million	402,400 Added 22.9%	2,159,800 $162 Million
Q2 2021 Aug 16, 2021	BUY	$70.31 - $77.77 $29.3 Million - $32.5 Million	417,400 Added 31.15%	1,757,400 $137 Million
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $46.5 Million - $54.7 Million	675,000 Added 101.5%	1,340,000 $103 Million
Q4 2020 Feb 16, 2021	BUY	$71.77 - $79.65 $1.56 Million - $1.73 Million	21,700 Added 3.37%	665,000 $54.4 Million
Q3 2020 Nov 16, 2020	BUY	$73.18 - $82.95 $15 Million - $17 Million	205,300 Added 46.87%	643,300 $53.4 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $6.77 Million - $7.7 Million	96,100 Added 28.11%	438,000 $33.9 Million
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $58.3 Million - $80.8 Million	-920,500 Reduced 72.92%	341,900 $26.3 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $17.4 Million - $19.6 Million	224,200 Added 21.6%	1,262,400 $115 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $17.8 Million - $19.4 Million	234,300 Added 29.15%	1,038,200 $87.4 Million
Q2 2019 Aug 14, 2019	BUY	$69.84 - $81.59 $14.9 Million - $17.5 Million	214,000 Added 36.28%	803,900 $67.4 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $18.8 Million - $21.5 Million	270,800 Added 84.86%	589,900 $49.1 Million
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $10.1 Million - $11.8 Million	155,200 Added 94.69%	319,100 $24.4 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $5.19 Million - $6.11 Million	90,000 Added 121.79%	163,900 $11.6 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $3.76 Million - $4.41 Million	73,900 New	73,900 $4.49 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$24.5 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$20.3 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$11.7 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.43 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.8 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account